Sinha Vikas's Form 4 filing
Kalaris Therapeutics, Inc. (KLRS) · filed Oct 23, 2024
- Accession no.
- 0000950170-24-116648
- Filed
- Oct 23, 2024
- Trade date
- Oct 21-22, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.66K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sinha VikasCIK 0001337845 | Director, Officer (See Remarks), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 21, 2024 | Common Stock | SSaleDisposed | −1,546 | $0.78 | −$1,205.88 | 1,151,098 | Direct | |
| Oct 22, 2024 | Common Stock | SSaleDisposed | −1,882 | $0.77 | −$1,449.14 | 1,149,216 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.